Functional Microarray Augmentation of Skin Treatment With Lidocaine

NCT01145326 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

WITHDRAWN

Status

OTHER

Sponsor class

Stopped The device is undergoing further study in China, per FDA requirements.

Conditions

Pain Perception
Phlebotomy

Interventions

DRUG: 4% lidocaine gel application with sham microneedle device
DRUG: Microneedle-facilitated lidocaine application

Sponsor

University of Oklahoma